Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2905–2928 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Brain Blood Flow, Neurovascular Control
Interventions: MRI, Transcranial Doppler Ultrasound, Sympathetic Nerve Activity; Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 45 Years to 68 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Sexual Dysfunction, Sexuality and Reproductive Issues
Interventions: counseling intervention, questionnaire administration, psychosocial assessment and care; Other · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 120 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2018
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Inflammation, Fatigue
Interventions: Riluzole, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Older Adults With Cognitive Decline, Older Adults, AI-Based Fitness, Wearables, Cognitive Decline, Physical Activity, Physical Inactivity
Interventions: Fitness app for self-efficacy, Social network via app for social support, Health education app targeting outcome expectations; Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 65 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Knoxville, Tennessee

Conditions: Executive Dysfunction, Depression, Stroke
Interventions: AKL-T01, Metacognitive Strategy Training; Device · Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 50 Years to 79 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer, Hot Flashes, Sexual Dysfunction, Fertility, Contraception
Interventions: Reproductive Health Survivorship Care Plan (SCPR), Control; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Alzheimer Disease, Hearing Loss, Cognitive Impairment
Interventions: Hearing Intervention, Health Education Intervention; Device · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Meibomian Gland Dysfunction, MGD-Meibomian Gland Dysfunction
Interventions: 0.3% Topical Minocycline Ointment, 1% Topical Minocycline Ointment, Topical Vehicle Ointment; Drug · Other
Lead sponsor: Hovione Scientia Limited; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 20
States / cities: Azusa, California • Huntington Beach, California • Inglewood, California + 16 more

Conditions: Sacroiliac Joint Somatic Dysfunction
Interventions: CornerLoc SI Joint Stabilization Procedure, Intra-articular Sacroiliac Joint Steroid Injection; Device · Drug
Lead sponsor: CornerLoc; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Cognitive Dysfunction
Interventions: Fluoxetine, Placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Duarte, California • Los Angeles, California

Conditions: Cognitive Decline
Interventions: Phyical/Cognitve Exercise; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Spinal Cord Injury Cervical, Upper Extremity Dysfunction
Interventions: Transcutaneous spinal stimulation, Physical therapy; Device · Other
Lead sponsor: University of Washington; Other
Eligibility: 21 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hypogonadism, Erectile Dysfunction
Interventions: Fispemifene (once daily for 8 weeks); Drug
Lead sponsor: QuatRx Pharmaceuticals Company; Industry
Eligibility: 20 Years and older · Male only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 14
States / cities: Birmingham, Alabama • Tucson, Arizona • Hot Springs, Arkansas + 11 more

Conditions: Preclinical Alzheimer's Disease, Alzheimer's Disease (AD)
Interventions: NAV4694; Radiation
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 80 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 56
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 48 more

Conditions: Post-Operative Delirium, Postoperative Cognitive Dysfunction
Interventions: SctO2 < 60 %.; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstetric Labour, Premature, Premature Ejaculation
Interventions: GSK221149; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Acute Lymphoblastic Leukemia
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years to 39 Years
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Aging, Mild Cognitive Impairment
Interventions: TH9507 human growth hormone releasing hormone (GHRH); Drug
Lead sponsor: University of Washington; Other
Eligibility: 55 Years to 90 Years
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Depression in Old Age, Recurrence, Cognitive Dysfunction
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years and older
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Trier Social Stress Test; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mild Cognitive Impairment, Memory Disorders, Mild Dementia, Impaired Cognition, Mild Cognitive Disorder, Amnestic Disorder, Dementia and Amnestic Conditions, Poor Short-term Memory, Memory Impairment
Interventions: Cognitive Rehabilitation, Computer Brain Fitness Training, Support Group (patient and partner), Wellness Education, Physical Exercise; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years and older
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Postural Tachycardia Syndrome
Interventions: Lower Body Negative Pressure, Sham Pressure; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Mild Cognitive Impairment
Interventions: Aerobic exercise, Stretching; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 60 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Hyper-IgM, DiGeorge Syndrome, Chediak-Higashi Syndrome, Common Variable Immune Deficiency, Immune Dysregulatory Disorders, Hemophagocytic Lymphohistiocytosis, IPEX, Autoimmune Lymphoproliferative Syndrome, X-linked Lymphoproliferative Syndrome
Interventions: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Up to 21 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Cardiovascular and Neurovascular Regulation in GWI

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

A Digital Intervention for Post-Stroke Depression and Executive Dysfunction

Reproductive Health Survivorship Care Plan

Early Age-Related Hearing Loss Investigation (EARHLI)

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Comparison of CornerLoc SI Joint Stabilization and Steroid Injections for Sacroiliac Joint Dysfunction

Fluoxetine Prevention Trial

Manipulating Cognitive Intensity During Aerobic Exercise

Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury

Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors

Alzheimer's Plasma Extension

Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

SMART: Somatotrophics, Memory, and Aging Research Trial

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

Behavioral Interventions to Prevent or Delay Dementia

fMRI in Postural Tachycardia Syndrome

Aging Brain Structure and Memory in Response to Exercise

Immune Disorder HSCT Protocol